<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To determine the response of bone marrow progenitor cells from patients with <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) to culture in physiologic oxygen tension </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: <z:chebi fb="0" ids="53448">Methylcellulose</z:chebi> progenitor assays using both unfractionated bone marrow mononuclear cells (MNCs) and purified CD34(+) progenitors were performed in atmospheric oxygen (18.6% <z:chebi fb="0" ids="15379">O(2)</z:chebi>) or one of two levels of <z:mp ids='MP_0005039'>hypoxia</z:mp> (1% and 3% <z:chebi fb="0" ids="15379">O(2)</z:chebi>) </plain></SENT>
<SENT sid="2" pm="."><plain>Assays were performed using <z:mpath ids='MPATH_458'>normal</z:mpath> donor marrow, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patient marrow, <z:hpo ids='HP_0004808'>acute myelogenous leukemia</z:hpo> marrow or peripheral blood blasts, <z:hpo ids='HP_0011010'>chronic</z:hpo> phase <z:hpo ids='HP_0005506'>chronic myelogenous leukemia</z:hpo> (<z:mp ids='MP_0005481'>CML</z:mp>) marrow MNCs, and <z:e sem="disease" ids="C0005699" disease_type="Neoplastic Process" abbrv="">blast crisis</z:e> <z:mp ids='MP_0005481'>CML</z:mp> peripheral blood </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: The majority of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> samples showed decreased colony-forming units (CFU) in 18.6% <z:chebi fb="0" ids="15379">O(2)</z:chebi> compared to <z:mpath ids='MPATH_458'>normal</z:mpath> controls, as expected </plain></SENT>
<SENT sid="4" pm="."><plain>However, in either 1% or 3% <z:chebi fb="0" ids="15379">O(2)</z:chebi>, 9 of 13 MDS samples demonstrated augmentation of CFUs beyond that observed in <z:mpath ids='MPATH_458'>normal</z:mpath> controls, with 6 of 13 demonstrating a greater than ninefold augmentation </plain></SENT>
<SENT sid="5" pm="."><plain>This effect is cell autonomous, as it persisted after purification of CD34(+) progenitor cells </plain></SENT>
<SENT sid="6" pm="."><plain>Additionally, the augmented response to physiologic oxygen tension is specific to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>, as it was not observed in either <z:hpo ids='HP_0011009'>acute</z:hpo> or <z:hpo ids='HP_0005506'>chronic myelogenous leukemia</z:hpo> samples </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSION: These results suggest that the reported decrease in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> CFUs reflects greater sensitivity of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> progenitors or their progeny to the nonphysiologic oxygen tensions routinely used in vitro, rather than a true decrease in progenitor frequency </plain></SENT>
<SENT sid="8" pm="."><plain>Importantly, these experiments for the first time describe an experimental system that can be used to study the growth of primary cells from patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
</text></document>